Results 1 to 10 of about 1,463 (157)
Transient Efficacy of Tofacitinib in Alopecia Areata Universalis [PDF]
Case Reports in Dermatology, 2016 Alopecia areata is a common autoimmune disorder that targets hair follicles. Swarms of lymphocytes surround the basis of the follicles, inducing loss of pigmented terminal hair and subsequently inhibit further hair growth.
Florian Anzengruber +5 more
doaj +8 more sources
Rapid hair regrowth in an alopecia universalis patient with deucravacitinib: A case report
SAGE Open Medical Case Reports, 2023 Alopecia universalis is a severe, difficult to treat variant of alopecia areata that results in loss of hair on the scalp, eyebrows, eyelashes, and extremities.
Elena Netchiporouk
exaly +2 more sources
Baricitinib improved morphoea manifestations in a patient with alopecia areata universalis. [PDF]
Skin Health DisIn our clinical case, the patient, affected by morphea, reported an excellent response to the administration of baricitinib 4 mg day–1, with rapid disappearance of itching and reduction of the erythematous-infiltrative component of the plaques, highlighting the important role of the JAK/STAT pathway in TGF-β-mediated profibrotic signalling.
Rubino V +6 more
europepmc +5 more sources
It is all alopecia areata: It is time to abandon the terms alopecia totalis and alopecia universalis [PDF]
Journal of the American Academy of Dermatology, 2022 Brittany Craiglow +2 more
exaly +3 more sources
Treatment outcomes and considerations for topical immunotherapy in patients with alopecia totalis and alopecia universalis [PDF]
Frontiers in MedicineBackgroundAlopecia areata (AA) is a chronic immune-mediated disorder causing non-scarring hair loss. Severe forms like alopecia totalis (AT) and alopecia universalis (AU) pose therapeutic difficult situations.
Taiyo Hitaka +6 more
doaj +2 more sources
Beard hair response in alopecia areata universalis treated with baricitinib. [PDF]
JAAD IntTrecarichi AC +4 more
europepmc +3 more sources
Acta Dermato-Venereologica, 2023 Alopecia areata is an autoimmune disorder characterized by hair loss, for which there are few treatment options. This claims-based study characterized recent real-world treatment patterns among patients in the USA with alopecia areata, including the ...
Nicolae Done +6 more
doaj +1 more source
Journal of Nepal Medical Association, 2021 Alopecia universalis is an uncommon form of alopecia areata involving hair loss over the entire scalp and body. This condition is difficult to treat and sustain the growth of hair for longer duration.
Vikash Paudel +4 more
doaj +1 more source
Improvement of atopic dermatitis and alopecia universalis with dupilumab: a case report
Dermatology Reports, 2021 Dupilumab is an interleukin (IL)-4 receptor alpha antagonist that showed significant improvement of atopic dermatitis (AD). Many reports have shown significant resolution of alopecia areata, alopecia universalis, and alopecia totalis after dupilumab ...
Lama Alotaibi +3 more
doaj +1 more source
SAGE Open Medical Case Reports, 2023 Alopecia areata is an autoimmune disease resulting in non-scarring hair loss. Alopecia areata can progress to become alopecia totalis (loss of hair from the entire scalp) or alopecia universalis (loss of hair form the entire body), with the progression ...
Selena Osman, Danya Traboulsi
doaj +1 more source